1.Diagnostic usefulness and limitations of the sural nerve biopsy.
Yonsei Medical Journal 1990;31(1):1-26
In recent years, the sural nerve biopsy has become a commonly performed procedure in the diagnostic work-up of patients with peripheral neuropathy. This paper reviews the diagnostic usefulness and limitations of this procedure. Based on 385 sural nerve biopsies, we found clinically helpful or relevant information in 45% of cases. In 24% of cases, specific diagnoses were obtained, among which vasculitic neuropathy was most common.
Biopsy/methods/standards
;
Evaluation Studies
;
Histological Techniques
;
Human
;
Peripheral Nervous System Diseases/classification/*diagnosis
;
Spinal Nerves/*pathology
;
Sural Nerve/*pathology
2.Using Sirolimus for Posttransplant Management and Reduction of Tuberous Sclerosis Complex Progression in a Patient with End Stage Renal Disease Caused by Tuberous Sclerosis Complex.
Kang Hun LEE ; Han Sae KIM ; Sung Han YUN ; Jin Ho LEE ; Joon Seok OH ; Seung Min KIM ; Yong Hun SIN ; Joong Kyung KIM
The Journal of the Korean Society for Transplantation 2014;28(4):241-245
Tuberous sclerosis complex (TSC) is a neurocutaneous disease characterized by the formation of hamartomas in multiple organs. TSC can show lesions including facial angiofibroma, shagreen patch on the skin, cortical tuber, subependymal nodule, astrocytoma in the brain, cardiac rhabdomyoma, and renal angiomyolipoma. In particular, renal angiomyolipoma may be a cause of end-stage renal disease (ESRD). On the other hand, sirolimus has regulatory effects on cellular growth and proliferation via its inhibitory effect on a protein, mammalian target of rapamycin. We report on a case of an 18-year-old male who underwent renal transplantation due to ESRD induced by TSC. Sirolimus played a role in successful treatment of TSC and effective immunosuppression for transplantation.
Adolescent
;
Angiofibroma
;
Angiomyolipoma
;
Astrocytoma
;
Brain
;
Hamartoma
;
Hand
;
Humans
;
Immunosuppression
;
Kidney Failure, Chronic*
;
Kidney Transplantation
;
Male
;
Rhabdomyoma
;
Sirolimus*
;
Skin
;
Tuberous Sclerosis*
3.Febuxostat for the Treatment of Chronic Tophaceous Gout in a Patient on Continuous Ambulatory Peritoneal Dialysis.
Jeong Hee YUN ; Hee Yeoun KIM ; Dong Han KIM ; Joon Seok OH ; Seong Min KIM ; Young Hun SIN ; Joong Kyung KIM
Korean Journal of Medicine 2015;89(2):229-232
Hyperuricemic patients with gouty arthritis or tophi, a serum uric acid concentration of 8.0 mg/dL or higher, and complications should be treated with urate-lowering drugs. Conventionally, allopurinol is used to treat hyperuricemia and gout, but it is necessary to adjust the dosage according to the degree of renal impairment. Uncommonly, allopurinol may have severe or fatal side effects. The non-purine xanthine oxidase inhibitor febuxostat undergoes hepatic metabolism and may require less dose adjustment in association with renal function. It is considered to be an alternative treatment for hyperuricemic patients with chronic kidney disease. Our experience suggests that low-dose febuxostat is a promising alternative to allopurinol for the treatment of gouty arthritis or tophi in peritoneal dialysis patients.
Allopurinol
;
Arthritis, Gouty
;
Gout*
;
Humans
;
Hyperuricemia
;
Kidney Failure, Chronic
;
Metabolism
;
Peritoneal Dialysis
;
Peritoneal Dialysis, Continuous Ambulatory*
;
Renal Insufficiency, Chronic
;
Uric Acid
;
Xanthine Oxidase
;
Febuxostat